Literature DB >> 16098705

Patients' experiences related to anti-viral treatment for hepatitis C.

Liana Fraenkel1, Sarah McGraw, Suchat Wongcharatrawee, Guadalupe Garcia-Tsao.   

Abstract

OBJECTIVE: To conduct a qualitative study to elicit patients' descriptions of their own experiences with treatment for hepatitis C (HCV).
METHODS: Focus groups were conducted until thematic saturation was reached.
RESULTS: A total of 40 patients (80% male) participated in eight focus groups. The themes that emerged most frequently during the focus groups centered on adverse effects and quality of care. The discussions highlighted discrepancies between patients' anticipated effects of drug toxicity versus their actual experiences, gaps in communication between physicians, and the lack of social support as important shortcomings in the healthcare of HCV patients.
CONCLUSIONS: The issues raised by the participants in this study highlight several important areas that may lead to improved care for patients with HCV. PRACTICE IMPLICATIONS: This study suggests that care for patients with HCV might be improved by using patient testimonials to improve accuracy of expectations, having both the primary care physician and liver specialist devise a plan to treat symptoms arising during the course of therapy, and ensuring that patients have the option of participating in a support group.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098705     DOI: 10.1016/j.pec.2005.06.019

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  14 in total

Review 1.  A systematic review of provider knowledge of hepatitis C: is it enough for a complex disease?

Authors:  Susan L Zickmund; Kyle E Brown; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

2.  Mental and physical symptoms associated with lower social support for patients with hepatitis C.

Authors:  Julie A Blasiole; Laura Shinkunas; Douglas R Labrecque; Robert M Arnold; Susan L Zickmund
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

3.  A pilot training program for a motivational enhancement approach to hepatitis C virus treatment among individuals in Israeli methadone treatment centers.

Authors:  Diane S Morse; Miriam Schiff; Shabtay Levit; Rinat Cohen-Moreno; Geoffrey C Williams; Yehuda Neumark
Journal:  Subst Use Misuse       Date:  2012-01       Impact factor: 2.164

4.  Social support and clinical outcomes during antiviral therapy for chronic hepatitis C.

Authors:  Donna M Evon; Denise A Esserman; Darmendra Ramcharran; Jason E Bonner; Michael W Fried
Journal:  J Psychosom Res       Date:  2011-06-30       Impact factor: 3.006

5.  Physical, social, and psychological consequences of treatment for hepatitis C : a community-based evaluation of patient-reported outcomes.

Authors:  M Michele Manos; Chanda K Ho; Rosemary C Murphy; Valentina A Shvachko
Journal:  Patient       Date:  2013       Impact factor: 3.883

6.  Patients' preferences for treatment of hepatitis C.

Authors:  Liana Fraenkel; Diane Chodkowski; Joseph Lim; Guadalupe Garcia-Tsao
Journal:  Med Decis Making       Date:  2009-07-27       Impact factor: 2.583

7.  Psychosocial issues in hepatitis C: a qualitative analysis.

Authors:  E Amy Janke; Sarah McGraw; Guadalupe Garcia-Tsao; Liana Fraenkel
Journal:  Psychosomatics       Date:  2008 Nov-Dec       Impact factor: 2.386

8.  Experienced continuity of care when patients see multiple clinicians: a qualitative metasummary.

Authors:  Jeannie L Haggerty; Danièle Roberge; George K Freeman; Christine Beaulieu
Journal:  Ann Fam Med       Date:  2013 May-Jun       Impact factor: 5.166

9.  Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriers.

Authors:  Donna M Evon; Carol E Golin; Jason E Bonner; Catherine Grodensky; Jennifer Velloza
Journal:  J Clin Gastroenterol       Date:  2015 May-Jun       Impact factor: 3.062

Review 10.  Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors.

Authors:  Magdalena Harris; Tim Rhodes
Journal:  Harm Reduct J       Date:  2013-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.